BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright: ©Author(s) 2026.
World J Clin Pediatr. Dec 9, 2026; 15(4): 120054
Published online Dec 9, 2026. doi: 10.5409/wjcp.120054
Table 1 Demographic and clinical characteristics of patients, median (interquartile range)/n (%)
Characteristics
Total, n = 175
Survivors, n = 151
Non-survivors, n = 24
P value
Age in months48 (12-126)42 (12-132)54 (4.7-102)0.845
Age subgroups
1-12 months5649 (87.5)7 (12.5)0.686
13-60 months4640 (87)6 (13)
61-120 months2923 (79.3)6 (20.7)
> 120 months4439 (88.6)5 (11.4)
Gender
Male9685 (88.5)11 (11.5)0.339
Female7966 (83.5)13 (16.5)
Primary diagnosis
Respiratory disease4141 (100.0)00.372
Renal disease22 (100.0)0
Sepsis3015 (50.0)15 (50.0)
Neurological disease4341 (95.2)2 (4.7)
Cardiac disease1010 (100.0)0
Postoperative11 (100.0)0
Oncology86 (75.0)2 (25.0)
Trauma21 (50.0)1 (50.0)
Endocrine404 (100.0)
Hepatic disease64 (66.7)2 (33.3)
Poisoning99 (100.0)0
Metabolic disease101 (100.0)
Gastrointestinal disease1817 (94.4)1 (5.6)
Mechanical ventilation in first 24 hours259 (36)16 (64)< 0.001
Inotropes in first 24 hours2614 (53.8)12 (46.2)< 0.001
Duration of PICU stay (days)3 (1-5)3 (1-4)4 (2-7)0.031
Duration of total hospital stay (days)5 (4-9)6 (4-9)4 (2-7)0.011
Referred out137 (53.8)6 (46.2)0.231
Table 2 Comparison of pediatric risk of mortality score III, pediatric index of mortality-3, and pediatric logistic organ dysfunction score-2 mortality scores between survivors and non-survivors, mean ± SD/median (interquartile range)

Survivors, n = 151
Non survivors, n = 24
Total, n = 175
P value
AUROC (95%CI)
Observed death (O)
Expected death (E)
SMR (O/E) 95%CI
Calibration HL-GOF
PRISM-III4.35 ± 3.9213.04 ± 7.685.54 ± 5.55< 0.0010.884 (0.827-0.927)24231.04 (0.63-0.46)χ2 = 2.69, P = 0.952
3 (2-6)10.5 (6-18)4 (2-7)
PIM-32.52 ± 1.7518.79 ± 28.314.75 ± 1.84< 0.0010.951 (0.907-0.978)24241.0 (0.64-1.47)χ2 = 5.592, P = 0.692
2.1 (1.6-2.8)8.6 (4-13.5)2.3 (1.7-3.5)
PELOD-21.74 ± 2.087.08 ± 4.202.47 ± 3.07< 0.0010.939 (0.893-0.970)24231.04 (0.63-1.46)χ2 = 7.36, P = 0.518
2 (0-2)7 (4-9)2 (0.6-3)
Table 3 Age-stratified predictive performance of pediatric risk of mortality score III, pediatric index of mortality-3, and pediatric logistic organ dysfunction score-2 mortality scores

PRISM-III
PIM-3
PELOD-2
Age group 1-12 months
mean ± SD4.52 ± 5.484.85 ± 11.702.64 ± 2.75
median (interquartile range)3 (1.5-6)2.6 (1.9-3.1)2 (2-3)
AUROC (95%CI)0.856 (0.656-1.000)0.845 (0.550-1.000)0.883 (0.722-0.990)
Observed death (O)777
Expected death (E)767
SMR (O/E) 95%CI11.21
HL χ21.557.071.72
P value0.9070.530.423
Age group 13-60 months
mean ± SD5.61 ± 5.615.19 ± 13.742.26 ± 3.30
median (interquartile range)4 (2.2-6.8)2.3 (1.8-3.7)1.5 (0-2)
AUROC (95%CI)0.872 (0.701-1.000)0.976 (0.925-1.000)0.982 (0.938-1.000)
Observed death (O)666
Expected death (E)566
SMR (O/E) 95%CI1.211
HL χ25.842.586.14
P value0.4410.9580.105
Age group 61-120 months
mean ± SD6.97 ± 6.202.87 ± 2.573.14 ± 3.69
median (interquartile range)5 (2-10)2.1 (1.4-3.7)2 (0-6)
AUROC (95%CI)0.812 (0.635-0.953)0.884 (0.718-1.000)0.783 (0.530-0.971)
Observed death (O)666
Expected death (E) 656
SMR (O/E) 95%CI11.21
HL χ27.6512.064.17
P value0.4680.1490.383
Age group > 120 months
mean ± SD5.93 ± 5.065.41 ± 13.682.05 ± 2.77
median (interquartile range)5 (2-7)2.05 (1.6-3.55)1 (0-3)
AUROC (95%CI)0.849 (0.640-1.000)0.764 (0.333-1.000)0.879 (0.660-1.000)
Observed death (O)555
Expected death (E)545
SMR (O/E) 95%CI11.31
HL χ210.068.994.02
P value0.1850.3430.546
Table 4 Diagnostic accuracy of pediatric risk of mortality score III, pediatric index of mortality-3, and pediatric logistic organ dysfunction score-2 mortality scores
Mortality
Total, 175Sensitivity, %Specificity, %PPV, %NPV, %Diagnostic accuracy
Yes, 24
No, 151
PRISM-III> 617335070.878.13495.477.1
≤ 67118125
PIM-3> 3.619234279.284.845.296.284
≤ 3.65128133
PELOD-2> 3.821295087.580.84297.681.7
≤ 3.83122125


Write to the Help Desk